Today, the CEO of EKSO BIONICS (EKSO), Jack Peurach, sold shares of EKSO for $43.07K.
In addition to Jack Peurach, 2 other EKSO executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on EKSO BIONICS’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $3.62 million and GAAP net loss of $6.55 million. In comparison, last year the company earned revenue of $2.52 million and had a GAAP net loss of $7.9 million. Currently, EKSO BIONICS has an average volume of 53.08K. The Company has a Price to Book ratio of 19.2136.
Jack Peurach’s trades have generated a 95.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other.